NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal

The addition of ipilimumab to nivolumab did not statistically improve overall response rate, PFS, or OS but may harbor increased toxicity. Paired blood samples identified TIGIT expression on peripheral T cells as a compensatory change unique to dual PD-1 plus CTLA-4 blockade.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2026-01-07
DOI
https://doi.org/10.1200/jco-25-00929
Citations
1
Primary Topic
Colorectal and Anal Carcinomas
Type
article
Field-Weighted Citation Impact
39.15
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal

Cathy Eng, Christopher H. Lieu, Howard S. Höchster, Enrica Marmonti et al.
1 citations
Journal of Clinical Oncology
Colorectal and Anal Carcinomas
39.15
article

NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal

Cathy Eng, Christopher H. Lieu, Howard S. Höchster, Enrica Marmonti, Olivia Aranha, Cara Haymaker, Kristen K. Ciombor, Benjamin A. Weinberg, Tony F. Shields, Blasé N. Polite, Lianchun Xiao, Jennifer G. Whisenant, S. Iqbal, Syed Mohammad Ali Kazmi, John C. Krauss, Al B. Benson, Sarbajit Mukherjee, Van K. Morris, Joshua K. Ochieng, John Hays
article en
1 citations

Abstract

The addition of ipilimumab to nivolumab did not statistically improve overall response rate, PFS, or OS but may harbor increased toxicity. Paired blood samples identified TIGIT expression on peripheral T cells as a compensatory change unique to dual PD-1 plus CTLA-4 blockade.

Journal of Clinical OncologyVol. 44(6)
Rutgers, The State University of New Jersey (US), Northwestern University (US), University of Southern California (US), Baptist Hospital of Miami (US), The University of Texas MD Anderson Cancer Center (US), Georgetown University (US), Vanderbilt University (US), Washington University in St. Louis (US), University of Michigan (US), University of Chicago (US), The Barbara Ann Karmanos Cancer Institute (US), Vanderbilt-Ingram Cancer Center, University of Colorado Anschutz Medical Campus (US), The Ohio State University (US), The University of Texas Southwestern Medical Center (US), University of Colorado Denver (US)
Good health and well-being
Openalex Percentile: Top 2%
Colorectal and Anal Carcinomas
39.15
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.